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Mitochondrial DNA (mtDNA) mutations accumulate in a number of ageing tissues and are proposed to
play a role in the ageing process. We have previously shown that colonic crypt stem cells accumulate
somatic mtDNA point mutations during ageing. These mtDNA mutations result in the loss of the activity
of complex IV (cytochrome c oxidase (COX)) of the respiratory chain in the stem cells and their progeny,
producing colonic crypts which are entirely COX deﬁcient. However it is not known whether the other
complexes of the respiratory chain are similarly affected during ageing. Here we have used antibodies
to individual subunits of complexes I–IV to investigate their expression in the colonic epithelium from
human subjects aged 18–84. We show that in 50% of crypts with any form of respiratory chain deﬁ-
ciency, decreased expression of subunits of multiple complexes is observed. Furthermore we have
sequenced the entire mitochondrial genome of a number of cells with multiple complex defects and have
found a wide variety of point mutations in these cells affecting a number of different protein encoding
and RNA encoding genes. Finally we discuss the possible mechanisms by which multiple respiratory
chain complex defects may occur in these cells.
 2010 Elsevier Inc. Open access under CC BY license.1. Introduction
Mitochondria are the energy transducing organelles of eukary-
otic cells in which fuels to drive cellular metabolism are converted
to ATP. This occurs through the process of oxidative phosphoryla-
tion which is catalyzed by the four enzyme complexes of the respi-
ratory chain (NADH-ubiquinone oxidoreductase (complex I),
succinate-ubiquinone oxidoreductase (complex II), ubiquinol cyto-
chrome c oxidoreductase (complex III), cytochrome c oxidase
(complex IV)) and the ATP synthase (complex V). Complexes I–IV
transfer reducing equivalents which are the products of the citric
acid cycle and b-oxidation and pass them to molecular O2 to form
water. This transfer of electrons is associated with a free energy
change which is used by complexes I, III and IV to translocate pro-
tons from the matrix to the intermembrane space, and an electro-
chemical gradient is established (Chance and Mela, 1966). The ATP
synthase creates a hydrophilic pathway across the inner mitochon-
drial membrane which allows protons to ﬂow down their electro-
chemical gradient. As protons move through the ATP synthase theyfax: +44 (0)191 2824373.
bull).
 license.are used to drive the energetically unfavourable reaction between
ADP and Pi to form ATP (Alberts et al., 1998).
Mitochondria contain their own genome (mtDNA) which in hu-
mans is a circular, double stranded, 16.6 kb molecule present in
multiple copies within an individual cell. MtDNA encodes 13
essential polypeptides of the OXPHOS system as well as 22tRNAs
and 2 rRNAs (Anderson et al., 1981) giving the mitochondria their
own protein synthetic system. Mutations, arising either by genetic
or environmental insult, can affect all copies of the mitochondrial
genome within a cell (homoplasmy) or a cell can contain a mixture
of wild type and mutated mtDNA (heteroplasmy) (Taylor and
Turnbull, 2005). In the presence of heteroplasmy a biochemical de-
fect is observed only when a critical threshold of mutated mtDNA
to wild-type mtDNA is reached. The mechanism by which clonal
expansion of mutated mtDNA to high levels occurs is unknown.
A recent study showed that molecules with large scale deletions,
which are therefore smaller molecules, accumulate in mouse corti-
cal neurones faster than smaller deletions, and probably wild-type
molecules (Fukui and Moraes, 2009). Whilst this may explain the
clonal expansion of individual mtDNA deletions with age, it does
not explain the expansion of mtDNA point mutations as these mol-
ecules are identical in size to wild-type molecules. One theory is
that clonal expansion occurs by random genetic drift (Elson et al.,
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pendently of the cell cycle and not all molecules are always repli-
cated (relaxed replication (Bogenhagen and Clayton, 1977)). This
model suggests that relaxed replication of mtDNA coupled with
random degradation of some mtDNA molecules can lead, through
random intracellular drift, to one mutant genotype becoming the
dominant genotype of the cell.
Acquired mtDNA mutations have been proposed to play an
important role in ageing (Miquel et al., 1980) and mtDNA muta-
tions have been shown to accumulate in a number of ageing hu-
man tissues (Brierley, 1997; Brierley et al., 1998; Cottrell et al.,
2001a,b; Muller-Hocker, 1989, 1990; Muller-Hocker et al., 1992).
When mtDNA mutations clonally expand to a critical threshold le-
vel they may lead to respiratory deﬁciency which is demonstrated
by the presence of cells which are cytochrome c oxidase (COX)
deﬁcient. The ﬁrst documentation of the age-accumulation of
COX deﬁcient cells was by Muller-Hocker in 1989 who showed
that COX deﬁcient cardiomyocytes were not detectable before
the age of 20, but were detected in all subjects examined above
the age of 60 (Muller-Hocker, 1989). COX deﬁcient cells have since
been detected in a number of ageing tissues such as skeletal mus-
cle (Muller-Hocker, 1990), various neuronal cell types (Cottrell
et al., 2001a,b), colon (Taylor et al., 2003), stomach (McDonald
et al., 2008) and liver (Fellous et al., 2009). However the contribu-
tion of these cells to the ageing process remains controversial. A
mouse model with defective mitochondrial polymerase was devel-
oped to attempt to address the role of mtDNA mutations in ageing
(Kujoth et al., 2005; Trifunovic et al., 2004). These mice have an in-
crease in the frequency of mtDNA mutations compared to wild-
type mice and display a number of ageing phenotypes, e.g., hair
loss, kyphosis, reduced subcutaneous fat and osteoporosis, as well
as a signiﬁcantly reduced lifespan (Kujoth et al., 2005; Trifunovic
et al., 2004; Vermulst et al., 2007). However they begin to accumu-
late mutations during embryonic development and it is unknown
whether this occurs in humans. In addition a uniform distribution
of mutation frequency between tissue types is observed which
does not occur either in patients with mtDNA disease (Chinnery
and Turnbull, 1999) or during normal human ageing (Krishnan
et al., 2007). Therefore the relevance of these models to normal hu-
man ageing is unclear.
Studies on the role of mtDNA mutations in human ageing have
tended to focus on post-mitotic tissues such as heart, muscle and
neurons, whereas our recent studies have concentrated on repli-
cating tissues with a particular emphasis on possible stem cell
involvement. Human colon crypts provide an informative system
in which to study the potential impact of mtDNA mutations in
stem cell populations because the stem cell progeny are followed
readily as they migrate up the crypt before being lost into the
gut lumen. Thus crypts reﬂect the genotype of the stem cells at
the base of the crypt. We have shown that mtDNA point mutations
accumulate in human colonic stem cells with age, and that they ex-
pand clonally to high levels (Greaves et al., 2006; Taylor et al.,
2003). Previously we have used a well-established technique to de-
tect respiratory chain deﬁciency due to mtDNA mutations: the
identiﬁcation of cells which are deﬁcient in COX but have normal
succinate dehydrogenase (SDH) activity (Old and Johnson, 1989).
COX contains subunits encoded by both the mitochondrial and nu-
clear genomes, whilst SDH is the catalytic part of complex II and is
entirely nuclear encoded. However, since COX is only one of 4
respiratory chain complexes, it is possible that the impact of clon-
ally expanded mtDNA mutations in human tissues with increasing
age is much greater than is apparent from the study of COX alone.
Complexes I and III of the respiratory chain also contain mtDNA en-
coded subunits but no histochemical techniques are available to
investigate complex I and III activity. However antibodies speciﬁc
to subunits of these complexes are commercially available andthese have been shown to detect a biochemical deﬁciency in pa-
tients with mtDNA disease (Hanson et al., 2002). To investigate
the true extent of respiratory chain deﬁciency in human colon
due to mtDNA mutations, we used monoclonal antibodies to indi-
vidual subunits of each of the four respiratory chain complexes to
investigate expression at the protein level and to determine COX
activity by histochemistry within the same crypts. In addition,
we investigated the molecular genetic defects present in crypts
with respiratory chain deﬁciency.2. Materials and methods
2.1. Patients and colonic samples
Colonic mucosal samples were collected from two sources. Sub-
jects (10) undergoing colon resection for colon cancer (age range
35–84 years); each sample of normal colonic mucosa was collected
at a distance of at least 12 cm from the edge of the tumour. Muco-
sal biopsies from patients (10) undergoing colonoscopy for a dis-
turbance of bowel function in whom no bowel pathology was
identiﬁed (age range 18–80 years). All persons gave informed con-
sent prior to inclusion in the study and ethical approval was ob-
tained by the Joint Ethics Committee of Newcastle and North
Tyneside Health Authority and the Northumberland Local Research
Ethics Committee.
2.2. Cytochrome c oxidase/succinate dehydrogenase histochemistry
and DNA isolation from single cells
Colon samples were mounted for sectioning and frozen in iso-
pentane previously cooled to 190 C in liquid nitrogen. Cryostat
sections (12 lm) were cut onto glass slides and incubated in COX
(100 lM cytochrome c, 4 mM diaminobenzidine tetrahydrochlo-
ride and 20 lg.ml1 catalase in 0.2 M phosphate buffer pH 7.0) at
37 C for 50 min. Sections were then washed in phosphate buffered
saline (3  5 min) and then incubated in SDH medium (130 mM
sodium succinate, 200 lM phenazine methosulphate, 1 mM so-
dium azide, 1.5 mM nitroblue tetrazolium in 0.2 M phosphate buf-
fer pH 7.0) at 37 C for 45 min. Sections were washed in phosphate
buffered saline, pH 7.4 (3  5 min), dehydrated in a graded ethanol
series (70%, 95%, 2  100%), cleared in Histoclear (National
Diagnostics, Atlanta, USA) and mounted in DPX. For laser microdis-
section, 20 lm cryostat sections were mounted on PEN (polyethyl-
enenaphthalate) membrane slides (Leica Microsystems), subjected
to sequential COX/SDH histochemistry as above and air-dried
after ethanol dehydration. Single colonocytes were cut into sterile
0.5 ml PCR tubes using a Leica Laser Microdissection (AS-LMD)
System, and lysed in standard lysis buffer (Taylor et al., 2003).
2.3. Sequencing of individual colonocytes
The entire sequence of the mitochondrial genome from micro-
dissected colonocytes was determined using the single cell lysate
(see above) as the DNA template. Cells underwent two rounds of
PCR as previously described (Taylor et al., 2001). PCR products
were cycle sequenced using ABI BigDye chemistries per standard
manufacturer’s protocols and anaylsed on an ABI3100 genetic ana-
lyser (Applied Biosystems). Sequences obtained were compared to
the rCRS and the homogenate sequence for that patient, using Seq-
Scape software (Applied Biosystems).
2.4. Mitochondrial complex subunit immunohistochemistry
Serial 10 lm transverse sections were cut and allowed to air dry
for 1 h at room temperature. Theywere then ﬁxed in 4% paraformal-
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in distilled water. The sections were then permeabilised in a graded
methanol series (70%, 95%, 100% v/v) over a period of 1 h. Endoge-
nous peroxidase activity was quenched by the addition of 0.3% (v/
v) hydrogen peroxide to the 95% methanol. The sections were than
rinsed in PBS containing 0.1% Triton-X for 5 min, then incubated
with antibodies to individual subunits of each of the oxidative phos-
phorylation enzyme complexes I–IV (complex I NDUFS3 10 lg/ml,
complex II FeS 5 lg/ml, complex III Core II 2 lg/ml, complex IV sub-
unit 1 5 lg/ml, Mitosciences) diluted in 4% BSA in PBST, for 1 h at
room temperature. They were then washed 3  5 min in PBST fol-
lowed by incubationwith a peroxidase-conjugated antibody (rabbit
anti-mouse Ig’s, 50 lg/ml; DAKO Ltd., Ely UK) for 1 h at room tem-
perature. Following 3  5 min washes in PBST, peroxidase activity
was demonstrated by incubating in 1.5 mM 3,30-diaminobenzidine
tetrahydrochloride and 0.01% (v/v) hydrogen peroxide in 0.1 M
phosphate buffer pH 7.4, for 5 min at room temperature. Sections
were then washed in distilled water, counterstained in Meyers
Haemalumfor20 sandwashed in running tapwater. Theywere then
dehydrated in a graded ethanol series (70%, 95%, 100%), cleared in
Histoclear (National Diagnostics, Atlanta, Georgia, USA) and
mounted inDPX (BDH laboratory supplies, Poole,UK). Adensitomet-
ric analysis programme (KS300, Axiovision) was used to assess the
protein expression levels. A crypt was deﬁned as deﬁcient for any
of the complex subunits if the intensity of staining was 50% or less
than that of positive crypts within the same subject.3. Results
Serial transverse colon sections were cut from mucosal biopsies
from 20 patients (aged 18–84 years) and histochemistry and
immunohistochemistry performed. A total of 3471 crypts were
examined for the expression levels of subunits of respiratory chainFig. 1. Respiratory chain deﬁciency in human colonic crypts. Example panel of serial tra
which are brown have COX activity, those which are blue have an absence of COX activity
bars 20 lm). The blue arrows show a crypt with reduced expression of subunits of com
complex I only.complexes I–IV. Fig. 1 shows an example panel of serial sections.
We observed that 11.2% (388 crypts) had absence, or reduced
expression, of one or more respiratory chain complex subunits.
Respiratory chain deﬁciency increased exponentially with age
(Fig. 2a) in a pattern identical with that observed in our previous
studies of COX deﬁciency in individual crypts (Taylor et al.,
2003). Of the 11% of crypts with decreased expression of respira-
tory chain subunits, 29.9% (116 crypts) had a decrease in only
one complex; 19.1% (74 crypts) in two complexes, and 51% (198
crypts) in three complexes (I, III and IV) (Fig. 2b). Although isolated
reduction of expression of complex I and complex IV subunits oc-
curred, we did not observe isolated complex III deﬁciency. Surpris-
ingly, we observed more isolated complex IV deﬁciency than
isolated complex I deﬁciency. Complex IV subunit I expression
was down-regulated in all crypts which showed no COX activity.
It was also reduced in 94.3% of the crypts which showed any respi-
ratory chain expression defects and there was a very close correla-
tion (R2 = 0.997) between percentage COX activity deﬁciency and
percentage crypts with decreased respiratory chain subunit
expression (Fig. 2c).
Next we investigated the potential mitochondrial genetic basis
for the observed decreased expression of respiratory chain subunits.
Due to the recessive nature of mtDNA mutations and the fact that
therearemultiple copiesof themitochondrial genomepresentwith-
in individual cells, a mtDNAmutation must expand clonally to high
levels before it causes a detectable biochemical defect. We have
shown previously that mtDNA mutations clonally expand with age
and that the frequencyof thesemutations increaseswith age (Taylor
et al., 2003). However we have investigated previously only cells
which are COX positive or COX deﬁcient based on activity. In the
present study we extended this analysis to examine cells that had
defective expression of either single ormultiple complexes to inves-
tigate the types of mtDNA mutation which are potentially patho-
genic. We isolated, by laser microdissection, 2 cells with complex Insverse crypt sections which have undergone (a) COX/SDH histochemistry (crypts
) and (b–e) immunohistochemistry to subunits of complexes I–IV, respectively (scale
plexes I, III and IV. The yellow arrows show a crypt with an expression defect in
Fig. 2. (a) Frequency of respiratory chain deﬁciency in human colonic crypts versus age. Respiratory chain deﬁciency deﬁned as any crypt showing down regulation of any of
the subunits of any complex. Subjects are grouped by decade, error bars show standard error of the mean (SEM). (b) The frequency of individual crypts with various degrees of
respiratory chain deﬁciency. (c) Correlation between COX deﬁciency and total respiratory chain deﬁciency.
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ciencies and sequenced the entire mitochondrial genomes. Due to
potential problems with low mtDNA copy number PCR (Yao et al.,
2007), all putative mutations were re-ampliﬁed from the original
DNA lysate and were sequenced in both the forward and reverse
directions. This strategy aimed to eliminate any errors due to either
ampliﬁcation of nuclear pseudogenes or errors introduced by the
DNA polymerase during PCR ampliﬁcation.
A wide variety of mutations were detected (Table 1). Fig. 3a–c
shows an example of cells isolated from crypts which had reduced
expression of the complex I subunit only, and cells from crypts
which had decreased expression of subunits of complexes I, III
and IV combined. The electropherograms showing the mutations
detected in those cells are shown in Fig. 3d–g. In the two cells with
isolated complex I defects we detected two homoplasmic muta-
tions in complex I genes. The ﬁrst, an m.10971G>A transition, pre-
dicts a tryptophan to termination codon substitution at position 71
(p.W71X) within NADH Dehydrogenase 4 encoded by the MT-ND4
gene, predicting the premature truncation of the protein. The sec-
ond, an m.13681A>G transition, predicts a p.T449A mutation in
NADH Dehydrogenase 5 (encoded by the MT-ND5 gene) (Fig. 3e).
This mutation has been reported previously as a polymorphic var-
iant (Brandon et al., 2005) and it is uncertain that this is causal forTable 1
Mutations found in cells taken from crypts with single and multiple complex deﬁciencies
Subject Cell Complex expression
defect
Mutation Gene
1 1 I,III,IV m.13681A>G MT-ND5
1 1 I,III,IV m.2559A>G MT-RNR2
1 3 I,III,IV m.9714G>A MT-CO3
1 5 I,III,IV m.5997G>A MT-CO1
1 6 I,III,IV m.1905G>A MT-RNR2
1 7 I,III,IV m.14704T>C MT-TE
1 8 I only m.13681A>G MT-ND5
2 1 I,III,IV m.10761T>C MT-ND4L
2 2 I,III,IV m.1101 A>G MT-ND4
2 3 I,III,IV m.9247G>A MT-CO3
2 4 I,III,IV m.15077G>A MT-CYB
2 8 I,III,IV m.13916G>A MT-ND5
2 9 I,III,IV m.2816G>A MT-RNR2
2 10 I only m.10971G>A MT-ND4
Single cells were laser-microdissected from colonic crypts with expression defects in sin
changes listed here are not present in the homogenate mtDNA sequence for that subject.
Database, (Wu et al., 2002). Abbreviations: T, threonine; A, alanine; G, glycine; S, serine
TERM, termination codon. The following databases were checked to determine whether t
www.mitomap.org/), (Brandon et al., 2005a); (ii) mtDB (http://www.genpat.uu.se/mtDBthe complex I defect in this cell. The same mutation was also de-
tected in a cell with multiple complex expression defects but this
cell contained a second change m.2559T>G in the MTRNR-2 gene
which we predict is the likely cause of the multiple respiratory
chain complex defects. In most cells, we detected a single clonally
expanded mtDNA point mutation only.
A number of different changes in both protein encoding genes
and RNA genes (see example electropherogram in Fig. 3d) were
found in cells with multiple complex expression defects (Table
1). All of the mutations found in protein encoding genes predicted
amino acid changes and all but one were present at levels >50%,
suggesting that they are pathogenic. There did not appear to be a
particular pattern of mutations, e.g., there was not a higher propor-
tion of mutations in one gene compared with the rest, and the
types of changes observed were similar to those which we have de-
tected previously in COX deﬁcient human colonic crypts (Greaves
et al., 2006; Taylor et al., 2003). We were unable to detect muta-
tions in 5 of the 18 cells sequenced.4. Discussion
In this investigation we have again demonstrated that respira-
tory chain deﬁcient crypts accumulate in human colon with age.





100 p.T449A Poor mtDB: 10/2704
50 – – Not reported
100 p.G170S Moderate Not reported
100 p.A32T Poor Not reported
100 – – Not reported
100 – – Not reported
100 p.T449A Poor mtDB: 10/2704
80 p.C98R High Not reported
50 p.S86G Poor mtDB: 1/2704
100 p.S14 N High Not reported
100 p.E111L Moderate mtDB: 2/2704
40 p.G526E High Not reported
100 – – Not reported
100 p.W71X High Not reported
gle and multiple complexes, and their entire mitochondrial genome sequenced. The
Amino acid conservation was assessed using the PIR-International Protein Sequence
; C, cysteine; R, arginine; N, asparagine; E, glutamic acid; L, lysine; W, tryptophan;
hese had previously been reported as mtDNA polymorphisms: (i) MITOMAP (http://
/), (Ingman and Gyllensten, 2006).
Fig. 3. Mutations in cells isolated from colonic crypts with single and multiple complex expression defects. Serial transverse sections which have undergone
immunohistochemistry for complexes I (a) and III (b), and COX/SDH histochemistry (c). The yellow arrow shows a crypt with isolated complex I deﬁciency, the red arrow
shows a crypt which has combined complex I, III and IV deﬁciency. (d) Electropherogram showing the 14704T>C transition found in the crypt with multiple complex
deﬁciency. This mutation is in the gene encoding the mitochondrial tRNA for glutamic acid (MT-TE). (e) Sequencing electropherogram showing the 13681A>G transition a
crypt with isolated complex I deﬁciency. This change predicts a threonine to alanine amino acid change at position 449 of MT-ND5. Wild type homogenate sequences are
shown in panels (f) and (g).
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complexes of the respiratory chain are involved in more than
50% of deﬁcient crypts. We have also shown that clonally expanded
point mutations of the mtDNA are present in crypts with reduced
expression of multiple complex subunits. Our previous studies
examined crypts using an assay which detects COX deﬁciency only
and in these studies we showed that the point mutations present
in COX deﬁcient crypts were not necessarily in COX encoding
genes. This suggests that it is likely that multiple complexes were
also affected in those crypts.
Our current data show that a point mutation is potentially able
to disrupt the entire respiratory chain; this raises questions as to
the mechanisms by which this may occur. A mutation in one of
the tRNA or rRNA encoding genes will impair protein translation
of some or all of the mtDNA encoded subunits of the respiratory
chain (Jacobs, 2003). Indeed patients with mutations in mitochon-
drial rRNA and tRNA genes have multiple complex deﬁciencies
(Hao and Moraes, 1996; Hinttala et al., 2006). However this does
not explain how mutations in protein encoding genes affect multi-
ple complexes. There is some evidence that the absence of one
complex can affect the stability of another. In cultured mammalian
cells with a known mutation in the cytochrome b subunit of com-
plex III, steady state levels of both complex I and complex III are
reduced (Acin-Perez et al., 2004). However in cell lines with a
mutation in the ND6 subunit of complex I, complex III remains nor-
mal, suggesting that complex I is dependent on complex III for itsstabilisation but complex III is stable in the absence of complex I
(Acin-Perez et al., 2004). Our study detected crypts deﬁcient in
complex I alone, but no crypts which were deﬁcient in complex
III alone which supports this hypothesis. Further, multiple complex
defects have been observed in patients with mutations in struc-
tural subunits of complex I (Hinttala et al., 2006) and complex III
(Bruno et al., 2003; Rana et al., 2000).
It has been proposed that the complexes of the respiratory
chain do not exist simply as individual complexes within the inner
mitochondrial membrane but that they associate to form ‘super-
complexes’ (Schagger and Pfeiffer, 2000) or ‘respirasomes’
(Acin-Perez et al., 2008). Recent data has shown that these super-
complexes are able to respire when isolated by blue native gel elec-
trophoresis (BNGE) and by the same method it was demonstrated
that supercomplexes are not formed if one of their component
complexes is absent (Acin-Perez et al., 2008). A recent study which
modelled mutations in structural subunits of COX in a Rhodobacter
sphaeroides model system reported that one of the mutations
caused an intrinsic proton leak, which is predicted to affect the
whole of the respiratory chain (Namslauer and Brzezinski, 2009).
This provides further evidence that the complexes interact very
closely and a defect of one complex may affect the stability of other
complexes.
In ﬁve of the cells sequenced we were unable to detect a clon-
ally expanded mtDNA point mutation. We do not know what
causes the respiratory chain defect in these cells, but there are a
578 L.C. Greaves et al. / Experimental Gerontology 45 (2010) 573–579number of possible explanations. We have previously searched for
large scale mtDNA deletions in human colonocytes without suc-
cess (Taylor et al., 2003) and on this basis we excluded the possi-
bility that deletions are the cause of the respiratory chain
defects. There may be multiple different mutations present at
low levels in these cells which act together to produce the bio-
chemical defect (Trifunovic and Larsson, 2008), or there may be
dominant mtDNA mutations which cause a biochemical defect at
low mutation levels (Sacconi et al., 2008). It is also possible that
nuclear encoded genes involved in mitochondrial protein import
or assembly may cause respiratory chain defects (Papadopoulou
et al., 1999; Sue et al., 2000).
We have shown that respiratory chain deﬁciency in the human
colon has a strong positive association with age. We have also
demonstrated for the ﬁrst time that multiple complexes of the
respiratory chain are affected simultaneously and that the COX/
SDH histochemical assay is an extremely effective method to iden-
tify cells which are respiratory chain deﬁcient and contain mtDNA
mutations. These studies also highlight the prevalence of this phe-
nomenon in an ageing stem cell population. Since clonally ex-
panded mtDNA mutations are also present in other human stem
cell populations (McDonald et al., 2008; Nekhaeva et al., 2002), it
is important to consider the impact of these changes on the human
ageing process, and further studies are required to investigate this.
Finally we have shown that human colonic mucosal crypts are a
highly informative model system for our understanding of mito-
chondrial genetics and mitochondrial function.
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